Abbisko Cayman Limited (HK:2256)
:2256
Want to see HK:2256 full AI Analyst Report?
Comparison Results
Abbisko Cayman Limited
HK$13.02
HK$7.44B
―
15.47%
3 Buy
0 Hold
0 Sell
Strong Buy
Alphamab Oncology
HK$11.90
HK$8.21B
-15.87
12.35%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$18.48
HK$16.94B
-9.33
135.71%
1 Buy
1 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$12.08
HK$11.04B
13.52
20.31%
2 Buy
0 Hold
0 Sell
Moderate Buy
CStone Pharmaceuticals
HK$5.34
HK$12.38B
-11.03
126.47%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$7.01
HK$3.91B
433.56
-37.92%
―
Performance Comparison
HK:2256
Abbisko Cayman Limited
10.00
1.19
13.51%
HK:9966
Alphamab Oncology
8.55
-0.43
-4.79%
HK:1672
Ascletis Pharma, Inc.
14.85
7.85
112.14%
HK:2142
HBM Holdings Ltd.
11.79
2.09
21.55%
HK:2616
CStone Pharmaceuticals
7.70
4.04
110.38%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
6.32
-4.68
-42.55%